Feline calicivirus vaccine and production thereof

Claim 2

A vaccine for immunizing cats against feline calicivirus comprising at least about 10 3 tissue culture infectious doses of an attenuated feline calicivirus per ml, which vaccine is capable of stimulating the production of protective feline calicivirus antibodies comparable to those produced by natural infections when parenterally administered into non-immune cats and without producing the usual pathological symptoms of disease due to feline calicivirus.

Claim 3

A vaccine for immunizing cats against feline calicivirus comprising at least about 10 3 tissue culture infectious doses of an attenuated feline calicivirus, which virus was attenuated by at least 10 one- to six-day serial passages through feline tissue cultures in a nutrient fluid at an incubation temperature of about 30°±2°C.

Claim 4

A vaccine for immunizing cats against feline calicivirus comprising at least about 10 3 tissue culture infectious doses of an attenuated feline calicivirus, which virus was attenuated by at least 10 one- to six-day serial passages through feline tissue cultures in a nutrient fluid at an incubation temperature of about 30°±2°C.

Claim 5

A vaccine for immunizing cats against feline calicivirus comprising from about 10 3 to about 10 8 tissue culture infectious doses of attenuated feline calicivirus serotype F-9 per ml, which virus was attenuated by at least 10 one- to six-day serial passages through feline tongue cell cultures in a nutrient fluid at an incubation temperature of about 30°±2°C.

Claim 6

A vaccine for immunizing cats against feline calicivirus comprising from about 10 3 to about 10 8 tissue culture infectious doses of attenuated feline calicivirus serotype F-9 per ml, which virus was attenuated by at least 10 one- to six-day serial passages through feline tongue cell cultures in a nutrient fluid at an incubation temperature of about 30°±2°C.

Claim 7

A vaccine for immunizing cats against feline calicivirus comprising a dry solid dosage unit form containing at least about 10 3 tissue culture infectious doses of an attenuated feline calicivirus, which virus was attentuated by at least 10 one- to six-day serial passages through feline tissue cultures in a nutrient fluid at an incubation temperature of about 30°±2°C, and made solid by drying at low temperature the fluid vaccine.

Claim 8

A vaccine for immunizing cats against feline calicivirus comprising a dry solid dosage unit form containing at least about 10 3 tissue culture infectious doses of an attenuated feline calicivirus, which virus was attentuated by at least 10 one- to six-day serial passages through feline tissue cultures in a nutrient fluid at an incubation temperature of about 30°±2°C, and made solid by drying at low temperature the fluid vaccine.

Claim 9

The vaccine of claim 4 wherein said feline calicivirus is the F-9 serotype.

Claim 10

A method of immunizing cats against feline calicivirus which comprises parenterally administering to a cat at least 1 ml of the claim 2 vaccine.

Claim 11

A method of immunizing cats against feline calicivirus which comprises parenterally administering to a cat at least 1 ml of the claim 3 vaccine.

Claim 12

A method of immunizing cats against feline calicivirus which comprises intramuscularly inoculating a cat with at least 1 ml of the claim 2 vaccine and about two weeks later so inoculating said cat again.

Claim 13

A method of immunizing cats against feline calicivirus which comprises intramuscularly inoculating a cat with at least 1 ml of the claim 2 vaccine and about 3-4 weeks later so inoculating said cat again.

Claim 14

A method of immunizing cats against feline calicivirus which comprises intramuscularly inoculating a cat with at least 1 ml of the claim 3 vaccine and about 3-4 weeks later so inoculating said cat again.

Claim 17

A method of immunizing cats against feline calicivirus which comprises intramuscularly inoculating a cat with at least 1 ml of the claim 9 vaccine and about 2-5 weeks later administering to said cat by the respiratory route from about 10 3 to about 10 8 tissue culture infectious doses of feline calicivirus in its live virulent unattenuated form.

Claim 18

A method of immunizing cats against feline calicivirus which comprises parenterally administering to a cat at least 1 ml of the claim 2 vaccine and about 2-5 weeks later administering to said cat by the respiratory route from about 10 3 to about 10 8 tissue culture infectious doses of feline calicivirus which has been attenuated according to the process which comprises introducing an inoculum of live infectious feline calicivirus into a nutrient fluid culture medium which is non-toxic to said virus and contains viable feline tongue cells, propagating said virus by incubating said inoculated fluid medium at a temperature of about 30°±2°C for a period of 1 to 6 days and thereafter separating an inoculum of said virus thereform and serially passing the virus through other such feline tongue cultures for a total of at least about 10 passages.

Claim 19

A method of immunizing cats against feline calicivirus which comprises intramuscularly inoculating a cat with at least 1 ml of the claim 10 vaccine and about 2-5 weeks later administering to said cat by the respiratory route from about 10 3 to about 10 8 tissue culture infectious doses of feline calicivirus attenuated according to the process which comprises introducing an inoculum of live infectious feline calicivirus into a nutrient fluid culture medium which is non-toxic to said virus and contains viable feline tongue cells, propagating said virus by incubating said inoculated fluid medium at a temperature of about 30°±2°C for a period of 1 to 6 days and thereafter separating an inoculum of said virus therefrom and serially passing the virus through other such feline tongue cultures for a total of at least about 10 passages.